
Please try another search
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment and consumables, such as molecular diagnostics tools and genome editing materials for biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and the food industry. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Ye Wang | 55 | 2002 | Co-Founder, President & Executive Director |
Jiange Meng | 55 | 2010 | Executive Chairman |
David R. Liu | - | 2024 | Member of Scientific Advisory Board |
Jiuan Pan | 57 | 2018 | Independent Non-Executive Director |
George McDonald Church | 71 | 2019 | Member of Advisory Board |
Carl H. June | 71 | 2024 | Member of Advisory Board |
Fangliang Zhang | 60 | 2022 | Co-Founder & Executive Director |
Li Zhu | 75 | 2010 | Chief Strategy Officer & Executive Director |
Chenyang Shi | 57 | 2024 | Independent Non-Executive Director |
Alphonse Galdes | 72 | 2024 | Independent Non-Executive Director |
Yiu Leung Cheung | 65 | 2024 | Independent Non-Executive Director |
Ross A. Grossman | 74 | 2024 | Independent Non-executive Director |
John Anthony Quelch | 74 | 2024 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review